Clinical Trial Update: Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bazedoxifene/conjugated estrogens for vasomotor symptoms of menopause has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Vaginal Atrophy

Drugs mentioned

• Duavee (bazedoxifene/conjugated estrogens)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Vaginal Atrophy | Phase 3 | Status: COMPLETED